-The Times of India NEW DELHI: Even as stent prices have been capped, the cost of the three main consumables used in angioplasty have, in many cases, become even more expensive than stents as hospitals try to make up for the huge margins they lost on stents. The modus operandi is same as in the case of stents before the price cap. Though the consumables are bought at a third or less...
More »SEARCH RESULT
Total Matching Records found : 196
I-Day launch goal for National Health Protection Scheme, aims to cover 10 crore poor families -Abantika Ghosh
-The Indian Express The ambitious scheme aims to cover over 10 crore “poor and vulnerable” families — an estimated 50 crore individual beneficiaries — with coverage of up to Rs 5 lakh per family per year. The Niti Aayog is working towards a launch on Independence Day of the government’s latest flagship National Health Protection Scheme, which was announced in the Union Budget Thursday. Top officials in the Aayog said that...
More »Syringe prices may fall by half or more in January 2018 -Rema Nagarajan
-The Times of India NEW DELHI: The All India Syringes and Needles Manufacturers Association has issued a circular to its members to print the maximum retail price (MRP) on the basis of a maximum of 75% margin from December 24, which is observed as Consumer Day, and to implement this latest by January 26 next year. It also wrote to all foreign manufacturers of syringes, urging them to join the effort to...
More »Health tips -K Sujatha Rao
-The Indian Express Instead of cancelling hospital licences, bring in patient centric laws, institutional capacity to enforce them. The grievous error in declaring a live baby dead by the capital’s Max Hospital, following closely on the heels of Fortis hospital charging exorbitant amounts for the treatment of a seven-year-old child diagnosed with dengue, seem to have pushed things to a tipping point. The government responded by cancelling the licence of Max — a...
More »Max Super Specialty made excessive profits on disposable syringes: CCI
-The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20. CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell...
More »
